Work

The PROTECT Study: A phase II, open-label trial of prophylactic skin toxicity therapy with clindamycin and triamcinolone in patients with glioblastoma treated with tumor-treating fields.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.tps2084

Authors: Mario E. Lacouture, Kwami Ketosugbo, Stephen W Dusza, Samuel A. Goldlust, Priya Kumthekar, Fabio Massaiti Iwamoto

Institutions: Memorial Sloan Kettering Cancer Center, Hackensack University Medical Center, Northwestern Memorial Hospital, Columbia University Irving Medical Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281707830

Cites:

Cited by:

Related to: 10